New Zealand-based medical device firm Wellumio has launched a subsidiary in California to accelerate US-based clinical trials and commercial rollout of its portable stroke detection device, Axana. The move also signals the company’s closer approach to regulatory approval. The device uses Pulsed Gradient Free Mapping technology to offer insights into the severity and extent of a stroke at the bedside, cutting time taken for detection and treatment.
TDSB, Peel and York among school boards in North America hit by ‘cyber incident’ – Toronto Star
Several school boards in North America, including TDSB, Peel, and York, were targeted by a cyber incident. This attack has caused disruptions in their operations
